通策医疗涨2.01%，成交额2.74亿元，主力资金净流入826.25万元

Core Viewpoint - Tongce Medical's stock has shown a positive trend with a year-to-date increase of 13.73%, reflecting strong market performance and investor interest [1][2]. Group 1: Stock Performance - As of January 19, Tongce Medical's stock price reached 45.73 CNY per share, with a trading volume of 2.74 billion CNY and a market capitalization of 204.55 billion CNY [1]. - The stock has experienced a 2.01% increase during the trading session on January 19, with significant net inflows of capital amounting to 826.25 million CNY [1]. - Over the past five trading days, the stock has risen by 8.01%, and over the last 20 days, it has increased by 11.37% [1]. Group 2: Financial Performance - For the period from January to September 2025, Tongce Medical reported a revenue of 2.29 billion CNY, representing a year-on-year growth of 2.56%, and a net profit attributable to shareholders of 514 million CNY, which is a 3.06% increase [2]. - The company has distributed a total of 392 million CNY in dividends since its A-share listing, with 340 million CNY distributed over the past three years [3]. Group 3: Shareholder Structure - As of January 10, the number of shareholders for Tongce Medical was 90,000, a decrease of 8.16% from the previous period, while the average number of shares held per shareholder increased by 8.89% to 4,969 shares [2]. - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF and Southern Zhongzheng 500 ETF, with some shareholders reducing their holdings [3].